Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
117287702 | 11728770 | 2 | F | 20070717 | 20160819 | 20151112 | 20160819 | EXP | ZA-BRISTOL-MYERS SQUIBB COMPANY-13851829 | BRISTOL MYERS SQUIBB | 1.00 | DY | M | Y | 2.18000 | KG | 20160819 | OT | ZA | ZA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
117287702 | 11728770 | 1 | PS | ATAZANAVIR SULFATE | ATAZANAVIR SULFATE | 1 | Transplacental | UNK | U | 21567 | CAPSULE, HARD | ||||||||
117287702 | 11728770 | 2 | SS | RITONAVIR. | RITONAVIR | 1 | Transplacental | UNK | U | 0 | |||||||||
117287702 | 11728770 | 3 | C | COMBIVIR | LAMIVUDINEIDOVUDINE | 1 | Transplacental | UNK | U | 0 | |||||||||
117287702 | 11728770 | 4 | C | ZIDOVUDINE (AZT) | 2 | Oral | 8.8 MG, UNK | Y | 0 | 8.8 | MG | ||||||||
117287702 | 11728770 | 5 | C | VAB-6 | 2 | Transplacental | UNK | U | 0 | ||||||||||
117287702 | 11728770 | 6 | C | PREGAMAL | 2 | Transplacental | UNK | U | 0 | ||||||||||
117287702 | 11728770 | 7 | C | ASCORBIC ACID. | ASCORBIC ACID | 1 | Transplacental | UNK | U | 0 | |||||||||
117287702 | 11728770 | 8 | C | PANADOL | ACETAMINOPHEN | 1 | Transplacental | UNK | U | 0 | |||||||||
117287702 | 11728770 | 9 | C | FOLIC ACID. | FOLIC ACID | 1 | Transplacental | UNK | U | 0 | |||||||||
117287702 | 11728770 | 10 | C | AUGMENTIN | AMOXICILLINCLAVULANATE POTASSIUM | 1 | Transplacental | UNK | U | 0 | |||||||||
117287702 | 11728770 | 11 | C | AMOXIL | AMOXICILLIN | 1 | Transplacental | UNK | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
117287702 | 11728770 | 1 | Product used for unknown indication |
117287702 | 11728770 | 2 | Product used for unknown indication |
117287702 | 11728770 | 3 | Product used for unknown indication |
117287702 | 11728770 | 4 | Product used for unknown indication |
117287702 | 11728770 | 5 | Product used for unknown indication |
117287702 | 11728770 | 6 | Product used for unknown indication |
117287702 | 11728770 | 7 | Product used for unknown indication |
117287702 | 11728770 | 8 | Product used for unknown indication |
117287702 | 11728770 | 9 | Product used for unknown indication |
117287702 | 11728770 | 10 | Product used for unknown indication |
117287702 | 11728770 | 11 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
117287702 | 11728770 | HO |
117287702 | 11728770 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
117287702 | 11728770 | Anaemia | |
117287702 | 11728770 | Foetal exposure during pregnancy | |
117287702 | 11728770 | Neonatal respiratory distress syndrome | |
117287702 | 11728770 | Premature baby |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
117287702 | 11728770 | 4 | 20070717 | 20070801 | 0 |